HRT FINANCIAL LP

Position in OCGN — Ocugen, Inc.

CIK 1475597 NEW YORK, NY

Position in OCGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$681,635

+$71,178 QoQ

Shares Held

376,594

+0.6% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $404,834,023 across 199 Biotechnology names. OCGN ranks #72 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$681,635	376,594	+0.6%	Shares	Defined	2026-05-14
2025-09-30	$610,457	374,514	+45.3%	Shares	Defined	2025-11-14
2025-06-30	$250,078	257,813	+48.7%	Shares	Defined	2025-08-14
2024-12-31	$139,566	173,375	-78.5%	Shares	Defined	2025-02-14
2024-03-31	$1,322,660	806,500	+221.1%	Shares	Defined	2024-05-13
2023-06-30	$136,399	251,196	-75.1%	Shares	Defined	2023-08-11
2023-03-31	$859,591	1,007,728	+221.9%	Shares	Defined	2023-05-12
2022-09-30	$557,303	313,092	+758.9%	Shares	Defined	2022-11-14
2021-12-31	$165,861	36,453	-93.6%	Shares	Defined	2022-02-14
2021-03-31	$3,876,119	570,857	+4917.2%	Shares	Defined	2021-05-17
2020-12-31	$20,821	11,378	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.